Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TRINITY BIOTECH PLC TRIB

Healthcare Medical Devices
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its... see more

Recent & Breaking News (NDAQ:TRIB)

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

GlobeNewswire April 4, 2024

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

GlobeNewswire March 28, 2024

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

GlobeNewswire March 8, 2024

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

GlobeNewswire February 15, 2024

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

GlobeNewswire February 13, 2024

Trinity Biotech to Present at Emerging Growth Conference

GlobeNewswire February 8, 2024

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

GlobeNewswire February 7, 2024

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

GlobeNewswire January 31, 2024

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

GlobeNewswire January 31, 2024

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

GlobeNewswire January 31, 2024

Trinity Biotech plc to Host Investor Call

GlobeNewswire January 30, 2024

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

GlobeNewswire December 27, 2023

Trinity Biotech Announces Management Changes

GlobeNewswire December 18, 2023

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

GlobeNewswire November 28, 2023

Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of Health

GlobeNewswire October 10, 2023

Trinity Biotech Announces Q2 2023 Financial Results

GlobeNewswire October 3, 2023

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results

GlobeNewswire September 27, 2023

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

GlobeNewswire September 11, 2023

Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System

GlobeNewswire August 7, 2023

Trinity Biotech Announces Q1 2023 Financial Results

GlobeNewswire July 6, 2023